Michael Adam Blady - Net Worth and Insider Trading
Michael Adam Blady Net Worth
The estimated net worth of Michael Adam Blady is at least $24 Million dollars as of 2024-09-23. Michael Adam Blady is the Director of Knight Therapeutics Inc and owns about 4,014,833 shares of Knight Therapeutics Inc (TSX:GUD) stock worth over $24 Million. Michael Adam Blady is also the Director of Golden Ridge Resources Ltd and owns about 295,800 shares of Golden Ridge Resources Ltd (TSXV:GLDN) stock worth over $22,185. Details can be seen in Michael Adam Blady's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Adam Blady has not made any transactions after 2021-03-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Adam Blady
Michael Adam Blady Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Adam Blady owns 2 companies in total, including Knight Therapeutics Inc (TSX:GUD) , and Golden Ridge Resources Ltd (TSXV:GLDN) .
Click here to see the complete history of Michael Adam Blady’s form 4 insider trades.
Insider Ownership Summary of Michael Adam Blady
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-26 | Director |
| TSXV:GLDN | Golden Ridge Resources Ltd | 2021-03-02 | Director |
Michael Adam Blady Latest Holdings Summary
Michael Adam Blady currently owns a total of 2 stocks. Among these stocks, Michael Adam Blady owns 4,014,833 shares of Knight Therapeutics Inc (TSX:GUD) as of July 26, 2019, with a value of $24 Million and a weighting of 99.91%. Michael Adam Blady also owns 295,800 shares of Golden Ridge Resources Ltd (TSXV:GLDN) as of March 2, 2021, with a value of $22,185 and a weighting of 0.09%.
Latest Holdings of Michael Adam Blady
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:GUD | Knight Therapeutics Inc | 2019-07-26 | 4,014,833 | 6.02 | 24,169,295 |
| TSXV:GLDN | Golden Ridge Resources Ltd | 2021-03-02 | 295,800 | 0.08 | 22,185 |
Holding Weightings of Michael Adam Blady
Michael Adam Blady Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Adam Blady has made a total of 0 transactions in Knight Therapeutics Inc (TSX:GUD) over the past 5 years. The most-recent trade in Knight Therapeutics Inc is the acquisition of 49,500 shares on July 26, 2019, which cost Michael Adam Blady around $368,280.
According to the SEC Form 4 filings, Michael Adam Blady has made a total of 13 transactions in Golden Ridge Resources Ltd (TSXV:GLDN) over the past 5 years, including 13 buys and 0 sells. The most-recent trade in Golden Ridge Resources Ltd is the acquisition of 5,500 shares on March 2, 2021, which cost Michael Adam Blady around $715.
Insider Trading History of Michael Adam Blady
- 1
Michael Adam Blady Trading Performance
GuruFocus tracks the stock performance after each of Michael Adam Blady's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Adam Blady is 14.57%. GuruFocus also compares Michael Adam Blady's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Adam Blady within 3 months outperforms 7 times out of 14 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Adam Blady's insider trading performs compared to the benchmark.
Performance of Michael Adam Blady
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.05 | | | | | |
| Relative Return to S&P 500(%) | -7.84 | | | | | |
Michael Adam Blady Ownership Network
Michael Adam Blady Owned Company Details
What does Knight Therapeutics Inc do?
Who are the key executives at Knight Therapeutics Inc?
Michael Adam Blady is the Director of Knight Therapeutics Inc. Other key executives at Knight Therapeutics Inc include Senior Officer Amal Khouri , Director & Director or Senior Officer of 10% Security Holder Jonathan Ross Goodman , and 10% Security Holder Sime Armoyan .
Knight Therapeutics Inc (TSX:GUD) Insider Trades Summary
Over the past 18 months, Michael Adam Blady made no insider transaction in Knight Therapeutics Inc (TSX:GUD). Other recent insider transactions involving Knight Therapeutics Inc (TSX:GUD) include a net purchase of 1,479,900 shares made by Sime Armoyan , a net sale of 65,000 shares made by Amal Khouri , and a net sale of 45,000 shares made by Robert Nathaniel Lande .
In summary, during the past 3 months, insiders sold 45,000 shares of Knight Therapeutics Inc (TSX:GUD) in total and bought 0 shares, with a net sale of 45,000 shares. During the past 18 months, 314,200 shares of Knight Therapeutics Inc (TSX:GUD) were sold and 1,734,100 shares were bought by its insiders, resulting in a net purchase of 1,419,900 shares.
Knight Therapeutics Inc (TSX:GUD)'s detailed insider trading history can be found in Insider Trading Tracker table.
Knight Therapeutics Inc Insider Transactions
Michael Adam Blady Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Adam Blady. Currently GuruFocus does not have mailing address information for Michael Adam Blady.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
